JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dumarey, N.
Right arrow Articles by Goldman, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dumarey, N.
Right arrow Articles by Goldman, S.
Journal of Nuclear Medicine Vol. 47 No. 4 625-632
© 2006 by Society of Nuclear Medicine


Clinical Investigation

Imaging Infection with 18F-FDG–Labeled Leukocyte PET/CT: Initial Experience in 21 Patients

Nicolas Dumarey, MD1, Dominique Egrise, PhD1, Didier Blocklet, MD1, Bernard Stallenberg, MD2, Myriam Remmelink, MD, PhD3, Véronique del Marmol, MD, PhD4, Gaëtan Van Simaeys, PhD1, Frédérique Jacobs, MD5 and Serge Goldman, MD, PhD1

1 Department of Nuclear Medicine and PET/Biomedical Cyclotron Unit, CUB-Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium; 2 Department of Medical Imaging, CUB-Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium; 3 Department of Pathology, CUB-Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium; 4 Department of Dermatology, CUB-Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium; and 5 Department of Infectious Diseases, CUB-Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium

Correspondence: For correspondence or reprints contact: Nicolas Dumarey, MD, Department of Nuclear Medicine, Université Libre de Bruxelles Hôpital Erasme, 808 route de Lennik, B-1070 Brussels, Belgium. E-mail: ndumarey{at}ulb.ac.be

The aim of this study was to assess the feasibility and the potential role of PET/CT with 18F-FDG–labeled autologous leukocytes in the diagnosis and localization of infectious lesions. Methods: Twenty-one consecutive patients with suspected or documented infection were prospectively evaluated with whole-body PET/CT 3 h after injection of autologous 18F-FDG–labeled leukocytes. Two experienced nuclear medicine physicians who were unaware of the clinical end-diagnosis reviewed all PET/CT studies. A visual score (0–3)—according to uptake intensity—was used to assess studies. The results of PET/CT with 18F-FDG–labeled white blood cell (18F-FDG–WBC) assessment were compared with histologic or biologic diagnosis in 15 patients and with clinical end-diagnosis after complete clinical work-up in 6 patients. Results: Nine patients had fever of unknown etiology, 6 patients had documented infection but with unknown extension of the infectious disease, 4 patients had a documented infection with unfavorable evolution, and 2 patients had a documented infection with known extension. The best trade-off between sensitivity and specificity was obtained when a visual score of ≥2 was chosen to identify increased tracer uptake as infection. With this threshold, sensitivity, specificity, and accuracy were each 86% on a patient-per-patient basis and 91%, 85%, and 90% on a lesion-per-lesion basis. In this small group of patients, the absence of areas with increased WBC uptake on WBC PET/CT had a 100% negative predictive value. Conclusion: Hybrid 18F-FDG–WBC PET/CT was found to have a high sensitivity and specificity for the diagnosis of infection. It located infectious lesions with a high precision. In this small series, absence of areas with increased uptake virtually ruled out the presence of infection. 18F-FDG–WBC PET/CT for infection detection deserves further investigation in a larger prospective series.

Key Words: imaging infection • 18F-FDG–labeled leukocytes • PET/CT


Related articles in JNM:

This Month in JNM

JNM 2006 47: 9a-10a. [Full Text]  



This article has been cited by other articles:


Home page
JNMHome page
C. J. Palestro
Radionuclide Imaging of Infection: In Search of the Grail
J. Nucl. Med., May 1, 2009; 50(5): 671 - 673.
[Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
R. Kumar, S. Basu, D. Torigian, V. Anand, H. Zhuang, and A. Alavi
Role of Modern Imaging Techniques for Diagnosis of Infection in the Era of 18F-Fluorodeoxyglucose Positron Emission Tomography
Clin. Microbiol. Rev., January 1, 2008; 21(1): 209 - 224.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. Meller, C.-O. Sahlmann, and A. K. Scheel
18F-FDG PET and PET/CT in Fever of Unknown Origin
J. Nucl. Med., January 1, 2007; 48(1): 35 - 45.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2006 by the Society of Nuclear Medicine.